Improved method to stratify lymphoma patients with risk of secondary central nervous system involvement: A multicenter retrospective analysis.
Sign Up to like & getrecommendations! Published in 2021 at "Hematological oncology"
DOI: 10.1002/hon.2928
Abstract: Secondary central nervous system (SCNS) involvement is an infrequent but universally fatal event in diffused large B-cell lymphoma. The occurrence rate of SCNS involvement is approximately 5% but comes with a poor prognosis ever after.… read more here.
Keywords: risk; secondary central; scns involvement; nervous system ... See more keywords
Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy – a supplementary analysis of JCOG0601
Sign Up to like & getrecommendations! Published in 2024 at "Annals of Hematology"
DOI: 10.1007/s00277-024-05620-3
Abstract: Secondary central nervous system involvement (sCNSi) in diffuse large B-cell lymphoma (DLBCL) is fatal. However, its features in patients with sCNSi who are categorized as lower risk by international prognostic index (IPI) or CNS-IPI are… read more here.
Keywords: central nervous; jcog0601; nervous system; analysis ... See more keywords
Comparison of the efficacy and safety of drug therapies for macular edema secondary to central retinal vein occlusion
Sign Up to like & getrecommendations! Published in 2018 at "BMJ Open"
DOI: 10.1136/bmjopen-2018-022700
Abstract: Objectives To evaluate the efficacy and safety of anti-vascular endothelial growth factor (VEGF) agents and corticosteroids for the treatment of macular oedema (ME) secondary to central retinal vein occlusion (CRVO). Design Systematic review and network… read more here.
Keywords: secondary central; ranibizumab; efficacy safety; central retinal ... See more keywords
De novo secondary central nervous system lymphoma: A real-world cohort study over two decades
Sign Up to like & getrecommendations! Published in 2025 at "Blood"
DOI: 10.1182/blood-2025-8085
Abstract: Secondary central nervous system lymphoma (SCNSL) involves CNS spread of systemic lymphoma, occurring at diagnosis (de novo) or at relapse. While SCNSL is associated with more aggressive disease and poorer prognosis, de novo presentation often… read more here.
Keywords: central nervous; nervous system; cns targeting; scnsl ... See more keywords
Cerebrospinal fluid IL-6 and IL-10 as promising diagnostic and therapeutic prognostic biomarkers for secondary central nervous system lymphoma
Sign Up to like & getrecommendations! Published in 2024 at "BMC Cancer"
DOI: 10.1186/s12885-024-13195-5
Abstract: Accurate diagnosis and therapeutic response to secondary central nervous system lymphoma (SCNSL) are challenges that need to be addressed. We assessed the value of cerebrospinal fluid (CSF) cytokine levels for diagnosis and post–therapeutic prognosis in… read more here.
Keywords: central nervous; nervous system; csf; system lymphoma ... See more keywords
Secondary central nervous system lymphoma: spectrum of morphological MRI appearances
Sign Up to like & getrecommendations! Published in 2018 at "Neuropsychiatric Disease and Treatment"
DOI: 10.2147/ndt.s157959
Abstract: Background Secondary central nervous system lymphoma (SCNSL) is a rare and aggressive disease, which is defined as secondary central nervous system (CNS) involvement in patients with systemic lymphoma. According to previous reports, SCNSL presents mostly… read more here.
Keywords: secondary central; system lymphoma; nervous system; central nervous ... See more keywords
Prevention and management of secondary central nervous system lymphoma
Sign Up to like & getrecommendations! Published in 2022 at "Haematologica"
DOI: 10.3324/haematol.2022.281457
Abstract: Secondary central nervous system (CNS) lymphoma (SCNSL) is defined by the involvement of the CNS, either at the time of initial diagnosis of systemic lymphoma or in the setting of relapse, and can be either… read more here.
Keywords: lymphoma; disease; central nervous; secondary central ... See more keywords